Ironwood Pharmaceuticals (IRWD) Total Liabilities (2009 - 2026)

Ironwood Pharmaceuticals has disclosed Total Liabilities across 18 years of filings, most recently posting $651.7 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $651.7 million, down 1.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $651.7 million (down 1.45% YoY), and the FY2025 annual result was $658.7 million, up 1.0% from the prior year.
• Total Liabilities came in at $651.7 million for Q1 2026 at Ironwood Pharmaceuticals, down from $658.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $950.0 million in Q2 2023 to a low of $442.8 million in Q2 2022.
• The 5-year median for Total Liabilities is $658.7 million (2025), against an average of $652.6 million.
• Across the five-year window, Total Liabilities jumped 114.54% in 2023 and fell 24.49% in 2024, its largest moves.
• Ironwood Pharmaceuticals' Total Liabilities stood at $448.1 million in 2022, then surged by 82.39% to $817.4 million in 2023, then decreased by 20.2% to $652.2 million in 2024, then increased by 1.0% to $658.7 million in 2025, then slipped by 1.07% to $651.7 million in 2026.
• The last three Total Liabilities figures came in at $651.7 million (Q1 2026), $658.7 million (Q4 2025), and $660.2 million (Q3 2025), per Business Quant data.